Report Scope & Overview:
Percutaneous Coronary Intervention Market size was valued at USD 8.78 Billion in 2023 to USD 20.53 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.86% during the forecast period (2023 - 2032).
The global Percutaneous Coronary Intervention market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Market Size and Growth:
The market size for PCI procedures and associated devices is substantial and is expected to grow due to factors such as aging populations, lifestyle changes, and the rising incidence of CAD risk factors such as hypertension, diabetes, and obesity. The market encompasses a wide range of devices and technologies used in diagnostic imaging, coronary angiography, balloon angioplasty, stent placement, and adjunctive therapies.
Key Components of the PCI Market:
Diagnostic Imaging: Diagnostic imaging modalities such as coronary angiography, intravascular ultrasound (IVUS), and optical coherence tomography (OCT) are essential for assessing coronary anatomy, identifying lesions, and guiding PCI procedures with high precision.
Balloon Catheters: Balloon catheters are used to inflate and dilate narrowed coronary arteries, restoring blood flow and improving myocardial perfusion. Balloon angioplasty is often performed as the initial step in PCI procedures to prepare the vessel for stent placement.
Coronary Stents: Coronary stents are implantable devices used to support and scaffold the coronary artery lumen following balloon angioplasty, preventing vessel recoil and reducing the risk of restenosis. Stents may be bare-metal stents (BMS) or drug-eluting stents (DES) coated with medications to inhibit neointimal hyperplasia and reduce restenosis rates.
Atherectomy Devices: Atherectomy devices are used to remove plaque and debulk atherosclerotic lesions within coronary arteries, offering an alternative or adjunctive treatment option for complex or calcified lesions resistant to conventional balloon angioplasty.
Market Trends:
Transradial Approach: The transradial approach to PCI, involving access through the radial artery in the wrist, has gained popularity due to reduced bleeding complications, faster recovery times, and improved patient comfort compared to the traditional transfemoral approach.
Bioresorbable Scaffolds: Bioresorbable vascular scaffolds (BVS) are temporary stents designed to provide mechanical support to the coronary artery during healing and then gradually resorb over time, leaving the vessel free of permanent metallic implants.
Fractional Flow Reserve (FFR): FFR-guided PCI utilizes pressure wires and physiological measurements to assess the hemodynamic significance of coronary lesions and guide treatment decisions, optimizing stent placement and reducing unnecessary interventions.
Challenges:
Restenosis and Stent Thrombosis: Restenosis and stent thrombosis remain potential complications of PCI procedures, particularly with bare-metal stents or DES, necessitating ongoing surveillance, dual antiplatelet therapy (DAPT), and adherence to optimal medical therapy.
Cost and Reimbursement: The cost of PCI procedures and associated devices, along with reimbursement policies and coverage limitations, may impact healthcare provider adoption and patient access to advanced interventional cardiology treatments.
Operator Training and Experience: PCI procedures require specialized training, technical skills, and clinical judgment to ensure procedural success, minimize complications, and optimize patient outcomes, highlighting the importance of operator competency and credentialing.
Market Segmentations:
Global Percutaneous Coronary Intervention Market: By Company
Abbott Vascular
Svelte Medical
Medtronic
Boston Scientific
Cordis
Terumo Medical
Amg International
Asahi Intecc
B. Braun
Global Percutaneous Coronary Intervention Market: By Type
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices
Global Percutaneous Coronary Intervention Market: By Application
Hospitals
Healthcare Centers
ASCs
Global Percutaneous Coronary Intervention Market: Regional Analysis
The regional analysis of the global Percutaneous Coronary Intervention market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Percutaneous Coronary Intervention market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Percutaneous Coronary Intervention in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Percutaneous Coronary Intervention in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Percutaneous Coronary Intervention in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Percutaneous Coronary Intervention in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 8.78 Billion |
| Market Size 2032 | USD 20.53 Billion |
| Compound Annual Growth Rate (CAGR) | 8.86% ( 2023-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Historical Data | 2019-2023 |
| Forecast Units | Value ( USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | Coronary Stents PTCA Catheters Coronary Guidewires Embolic Protection Devices |
| By Application | Hospitals Healthcare Centers ASCs |
| Key Companies Profiled | Abbott Vascular Svelte Medical Medtronic Boston Scientific Cordis Terumo Medical Amg International Asahi Intecc B. Braun |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Percutaneous Coronary Intervention Market Report:
Firstly, Percutaneous Coronary Intervention market report provides invaluable insights into market dynamics, encompassing factors like industry trends, consumer behavior, and competitive analysis. By understanding these dynamics, businesses can identify opportunities for growth and anticipate potential threats, empowering them to make informed decisions that align with their strategic objectives.
Secondly, the quality and reliability of market research reports are paramount. Trusted sources and rigorous methodologies ensure the accuracy and credibility of the data presented. This reliability instills confidence in businesses, enabling them to base their strategies on solid foundations and navigate uncertainties with greater certainty.
Thirdly, Percutaneous Coronary Intervention market research reports offer a cost-effective solution for accessing comprehensive market intelligence. Rather than investing time and resources in conducting extensive research internally, businesses can rely on these reports to deliver actionable insights in a fraction of the time. This efficiency translates into cost savings and allows organizations to allocate resources more strategically.
Moreover, Percutaneous Coronary Intervention market research reports provide deep insights into consumer behavior, helping businesses understand preferences, trends, and purchasing patterns. By leveraging this information, companies can tailor their products and services to meet evolving customer needs, fostering customer satisfaction and loyalty.
Lastly, Percutaneous Coronary Intervention market research reports aid in strategic planning by facilitating informed decision-making. From identifying growth opportunities to mitigating risks, these reports equip businesses with the knowledge needed to develop effective strategies that drive sustainable growth and maintain a competitive edge in the market.
Objectives of Percutaneous Coronary Intervention Market Study:
Understanding Market Dynamics: Percutaneous Coronary Intervention Market research reports aim to provide a comprehensive understanding of the market environment, including industry trends, consumer behavior, and competitive landscape. By analyzing market dynamics, businesses can make informed decisions and adapt their strategies to meet evolving market demands.
Identifying Growth Opportunities: Another objective of Percutaneous Coronary Intervention market research reports is to identify potential growth opportunities within the market. By analyzing market trends and consumer preferences, businesses can pinpoint areas of unmet needs or underserved segments, allowing them to develop targeted strategies to capitalize on these opportunities.
Assessing Competitor Strategies: Percutaneous Coronary Intervention Market reports also help businesses assess competitor strategies and market positioning. By analyzing competitor performance, product offerings, and marketing tactics, companies can identify competitive strengths and weaknesses, enabling them to refine their own strategies and gain a competitive advantage.
Mitigating Risks: Understanding market risks is another key objective of Percutaneous Coronary Intervention market reports. By conducting thorough market analysis, businesses can identify potential threats such as changing consumer preferences, regulatory changes, or new market entrants. This allows them to develop risk mitigation strategies to safeguard their business operations.
Informing Decision Making: Ultimately, the primary objective of Percutaneous Coronary Intervention market reports is to provide actionable insights that inform strategic decision-making. By providing data-driven insights and recommendations, market research reports empower businesses to make informed decisions regarding product development, marketing strategies, and resource allocation, ultimately driving business growth and profitability.
Frequently Asked Questions
Percutaneous Coronary Intervention Market size was valued at USD 8.78 Billion in 2023 to USD 20.53 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.86% during the forecast period (2023 - 2032).
Factors driving growth include increasing prevalence of coronary artery disease, advancements in interventional cardiology techniques and technology, rising demand for minimally invasive procedures, and expanding indications for PCI.
Challenges include the risk of procedural complications such as bleeding, restenosis, and stent thrombosis, variability in patient outcomes, reimbursement issues, and competition from alternative treatment modalities such as coronary artery bypass grafting (CABG) surgery.
Regions with high prevalence of coronary artery disease, such as North America, Europe, and certain parts of Asia-Pacific, exhibit significant demand for percutaneous coronary intervention procedures.
The market is expected to witness continued growth due to increasing adoption of PCI as the preferred treatment for coronary artery disease, advancements in stent technology and drug-eluting coatings, expansion of indications to include complex lesions and high-risk patients, and ongoing research into adjunctive therapies to improve outcomes and reduce complications associated with PCI procedures. Collaboration between interventional cardiologists, device manufacturers, and regulatory agencies will drive innovation and further enhance the safety and efficacy of percutaneous coronary intervention.
TABLE OF CONTENT
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Percutaneous Coronary Intervention Market Size Growth Rate by Type:
1.2.2 Coronary Stents
1.2.3 PTCA Catheters
1.2.4 Coronary Guidewires
1.2.5 Embolic Protection Devices
1.3 Market by Application
1.3.1 Global Percutaneous Coronary Intervention Market Growth by Application:
1.3.2 Hospitals
1.3.3 Healthcare Centers
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Percutaneous Coronary Intervention Market Perspective
2.2 Percutaneous Coronary Intervention Growth Trends by Region
2.2.1 Global Percutaneous Coronary Intervention Market Size by Region:
2.2.2 Percutaneous Coronary Intervention Historic Market Size by Region
2.2.3 Percutaneous Coronary Intervention Forecasted Market Size by Region
2.3 Percutaneous Coronary Intervention Market Dynamics
2.3.1 Percutaneous Coronary Intervention Industry Trends
2.3.2 Percutaneous Coronary Intervention Market Drivers
2.3.3 Percutaneous Coronary Intervention Market Challenges
2.3.4 Percutaneous Coronary Intervention Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Percutaneous Coronary Intervention Players by Revenue
3.1.1 Global Top Percutaneous Coronary Intervention Players by Revenue
3.1.2 Global Percutaneous Coronary Intervention Revenue Market Share by Players
3.2 Global Percutaneous Coronary Intervention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Percutaneous Coronary Intervention Revenue
3.4 Global Percutaneous Coronary Intervention Market Concentration Ratio
3.4.1 Global Percutaneous Coronary Intervention Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Percutaneous Coronary Intervention Revenue in 2023
3.5 Percutaneous Coronary Intervention Key Players Head office and Area Served
3.6 Key Players Percutaneous Coronary Intervention Product Solution and Service
3.7 Date of Enter into Percutaneous Coronary Intervention Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Percutaneous Coronary Intervention Breakdown Data by Type
4.1 Global Percutaneous Coronary Intervention Historic Market Size by Type
4.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Type
5 Percutaneous Coronary Intervention Breakdown Data by Application
5.1 Global Percutaneous Coronary Intervention Historic Market Size by Application
5.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Application
6 North America
6.1 North America Percutaneous Coronary Intervention Market Size
6.2 North America Percutaneous Coronary Intervention Market Growth Rate by Country:
6.3 North America Percutaneous Coronary Intervention Market Size by Country
6.4 North America Percutaneous Coronary Intervention Market Size by Country
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Percutaneous Coronary Intervention Market Size
7.2 Europe Percutaneous Coronary Intervention Market Growth Rate by Country:
7.3 Europe Percutaneous Coronary Intervention Market Size by Country
7.4 Europe Percutaneous Coronary Intervention Market Size by Country
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Percutaneous Coronary Intervention Market Size
8.2 Asia-Pacific Percutaneous Coronary Intervention Market Growth Rate by Region:
8.3 Asia-Pacific Percutaneous Coronary Intervention Market Size by Region
8.4 Asia-Pacific Percutaneous Coronary Intervention Market Size by Region
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Percutaneous Coronary Intervention Market Size
9.2 Latin America Percutaneous Coronary Intervention Market Growth Rate by Country:
9.3 Latin America Percutaneous Coronary Intervention Market Size by Country
9.4 Latin America Percutaneous Coronary Intervention Market Size by Country
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Percutaneous Coronary Intervention Market Size
10.2 Middle East & Africa Percutaneous Coronary Intervention Market Growth Rate by Country:
10.3 Middle East & Africa Percutaneous Coronary Intervention Market Size by Country
10.4 Middle East & Africa Percutaneous Coronary Intervention Market Size by Country
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Vascular
11.1.1 Abbott Vascular Company Detail
11.1.2 Abbott Vascular Business Overview
11.1.3 Abbott Vascular Percutaneous Coronary Intervention Introduction
11.1.4 Abbott Vascular Revenue in Percutaneous Coronary Intervention Business
11.1.5 Abbott Vascular Recent Development
11.2 Svelte Medical
11.2.1 Svelte Medical Company Detail
11.2.2 Svelte Medical Business Overview
11.2.3 Svelte Medical Percutaneous Coronary Intervention Introduction
11.2.4 Svelte Medical Revenue in Percutaneous Coronary Intervention Business
11.2.5 Svelte Medical Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Percutaneous Coronary Intervention Introduction
11.3.4 Medtronic Revenue in Percutaneous Coronary Intervention Business
11.3.5 Medtronic Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Detail
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Percutaneous Coronary Intervention Introduction
11.4.4 Boston Scientific Revenue in Percutaneous Coronary Intervention Business
11.4.5 Boston Scientific Recent Development
11.5 Cordis
11.5.1 Cordis Company Detail
11.5.2 Cordis Business Overview
11.5.3 Cordis Percutaneous Coronary Intervention Introduction
11.5.4 Cordis Revenue in Percutaneous Coronary Intervention Business
11.5.5 Cordis Recent Development
11.6 Terumo Medical
11.6.1 Terumo Medical Company Detail
11.6.2 Terumo Medical Business Overview
11.6.3 Terumo Medical Percutaneous Coronary Intervention Introduction
11.6.4 Terumo Medical Revenue in Percutaneous Coronary Intervention Business
11.6.5 Terumo Medical Recent Development
11.7 Amg International
11.7.1 Amg International Company Detail
11.7.2 Amg International Business Overview
11.7.3 Amg International Percutaneous Coronary Intervention Introduction
11.7.4 Amg International Revenue in Percutaneous Coronary Intervention Business
11.7.5 Amg International Recent Development
11.8 Asahi Intecc
11.8.1 Asahi Intecc Company Detail
11.8.2 Asahi Intecc Business Overview
11.8.3 Asahi Intecc Percutaneous Coronary Intervention Introduction
11.8.4 Asahi Intecc Revenue in Percutaneous Coronary Intervention Business
11.8.5 Asahi Intecc Recent Development
11.9 B. Braun
11.9.1 B. Braun Company Detail
11.9.2 B. Braun Business Overview
11.9.3 B. Braun Percutaneous Coronary Intervention Introduction
11.9.4 B. Braun Revenue in Percutaneous Coronary Intervention Business
11.9.5 B. Braun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Svelte Medical
Medtronic
Boston Scientific
Cordis
Terumo Medical
Amg International
Asahi Intecc
B. Braun
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast